Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
11.90
-0.15 (-1.24%)
At close: Dec 5, 2025, 4:00 PM EST
11.92
+0.02 (0.17%)
After-hours: Dec 5, 2025, 7:17 PM EST
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2024. The number of employees decreased by 700 or -43.75% compared to the previous year.
Employees
900
Change (1Y)
-700
Growth (1Y)
-43.75%
Revenue / Employee
$876,556
Profits / Employee
$84,333
Market Cap
624.99M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EBS News
- 18 days ago - Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access - GlobeNewsWire
- 24 days ago - Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors - GlobeNewsWire
- 4 weeks ago - Emergent BioSolutions: Solid Q3, Expecting Better Days To Come - Seeking Alpha
- 5 weeks ago - Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Emergent BioSolutions Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness - GlobeNewsWire
- 2 months ago - Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025 - GlobeNewsWire
- 2 months ago - Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone - GlobeNewsWire